Venture Capital
Crunching the numbers on the first half drought for biotech IPOs
Dive Brief:• Halfway through 2022, newly priced biotech stock offerings are off to their slowest pace in years as a deepening economic downturn …
Dive Brief:• Halfway through 2022, newly priced biotech stock offerings are off to their slowest pace in years as a deepening economic downturn …
